These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15122092)

  • 1. Mouse models of insulin resistance and type 2 diabetes.
    Postic C; Mauvais-Jarvis F; Girard J
    Ann Endocrinol (Paris); 2004 Feb; 65(1):51-9. PubMed ID: 15122092
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights into insulin resistance and type 2 diabetes from knockout mouse models.
    Kadowaki T
    J Clin Invest; 2000 Aug; 106(4):459-65. PubMed ID: 10953020
    [No Abstract]   [Full Text] [Related]  

  • 3. [Knockout mouse models for type 2 diabetes. Mice with insulin resistance].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():64-9. PubMed ID: 12355825
    [No Abstract]   [Full Text] [Related]  

  • 4. The Gordon Wilson Lecture. Lessons about the control of glucose homeostasis and the pathogenesis of diabetes from knockout mice.
    Kahn CR
    Trans Am Clin Climatol Assoc; 2003; 114():125-48. PubMed ID: 12813916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance.
    Blüher M; Michael MD; Peroni OD; Ueki K; Carter N; Kahn BB; Kahn CR
    Dev Cell; 2002 Jul; 3(1):25-38. PubMed ID: 12110165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes.
    Stenbit AE; Tsao TS; Li J; Burcelin R; Geenen DL; Factor SM; Houseknecht K; Katz EB; Charron MJ
    Nat Med; 1997 Oct; 3(10):1096-101. PubMed ID: 9334720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism: A is for adipokine.
    Muoio DM; Newgard CB
    Nature; 2005 Jul; 436(7049):337-8. PubMed ID: 16034406
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.
    Zisman A; Peroni OD; Abel ED; Michael MD; Mauvais-Jarvis F; Lowell BB; Wojtaszewski JF; Hirshman MF; Virkamaki A; Goodyear LJ; Kahn CR; Kahn BB
    Nat Med; 2000 Aug; 6(8):924-8. PubMed ID: 10932232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, hypertension and the insulin-responsive glucose transporter, GLUT4.
    Livingstone C; Dominiczak AF; Campbell IW; Gould GW
    Clin Sci (Lond); 1995 Aug; 89(2):109-16. PubMed ID: 7554750
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis.
    Minokoshi Y; Kahn CR; Kahn BB
    J Biol Chem; 2003 Sep; 278(36):33609-12. PubMed ID: 12788932
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
    Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
    Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in diabetes mellitus. Defective insulin-regulatable glucose transport plays an important role.
    Livingstone C; Gould GW
    Scott Med J; 1995 Apr; 40(2):37-9. PubMed ID: 7618066
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular insulin action and insulin resistance.
    Garvey WT; Birnbaum MJ
    Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):785-873. PubMed ID: 8304915
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetes in midlife: planting genetic time bombs.
    O'Rahilly S
    Nat Med; 1997 Oct; 3(10):1080-1. PubMed ID: 9334713
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
    Kim JK; Zisman A; Fillmore JJ; Peroni OD; Kotani K; Perret P; Zong H; Dong J; Kahn CR; Kahn BB; Shulman GI
    J Clin Invest; 2001 Jul; 108(1):153-60. PubMed ID: 11435467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
    Storz P; Döppler H; Wernig A; Pfizenmaier K; Müller G
    Eur J Biochem; 1999 Nov; 266(1):17-25. PubMed ID: 10542046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLUT4: a key player regulating glucose homeostasis? Insights from transgenic and knockout mice (review).
    Wallberg-Henriksson H; Zierath JR
    Mol Membr Biol; 2001; 18(3):205-11. PubMed ID: 11681787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease model: hyperinsulinemia and insulin resistance. Part A-targeted disruption of insulin signaling or glucose transport.
    Sone H; Suzuki H; Takahashi A; Yamada N
    Trends Mol Med; 2001 Jul; 7(7):320-2. PubMed ID: 11425641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
    Carvalho E; Kotani K; Peroni OD; Kahn BB
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E551-61. PubMed ID: 15928024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockout mice lacking GLUT4 glucose transporters.
    Dutour A
    Eur J Endocrinol; 1996 Apr; 134(4):421-2. PubMed ID: 8640287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.